Affinity Asset Advisors, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Affinity Asset Advisors, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,396,250
+44.7%
375,000
+150.0%
0.94%
+34.7%
Q2 2022$1,656,000
+333.5%
150,000
+650.0%
0.70%
+402.2%
Q4 2021$382,000
-89.7%
20,000
-86.7%
0.14%
-85.1%
Q3 2021$3,699,000
+42.2%
150,000
+50.0%
0.93%
+0.2%
Q2 2021$2,602,000
+234.0%
100,000
+306.5%
0.93%
+251.7%
Q1 2021$779,000
-14.3%
24,600
+25.5%
0.26%
-45.0%
Q4 2020$909,00019,6000.48%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders